CorMedix Inc
SWB:19KA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
CorMedix Inc
SWB:19KA
|
US |
|
B
|
Banca IFIS SpA
SWB:0I6
|
IT |
|
E
|
Eli Lilly and Co
XMUN:LLY
|
US |
|
F
|
Federal Home Loan Mortgage Corp
XMUN:FHL
|
US |
|
R
|
Relx PLC
SWB:RDEB
|
UK |
Wall St Price Targets
19KA Price Targets Summary
CorMedix Inc
According to Wall Street analysts, the average 1-year price target for 19KA is 12.487 EUR with a low forecast of 11.031 EUR and a high forecast of 16.761 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 19KA's stock price target?
Price Target
12.487
EUR
According to Wall Street analysts, the average 1-year price target for 19KA is 12.487 EUR with a low forecast of 11.031 EUR and a high forecast of 16.761 EUR.
What is the Revenue forecast for CorMedix Inc?
Projected CAGR
15%
The compound annual growth rate for Revenue over the next 8 years is 15%.
What is the Operating Income forecast for CorMedix Inc?
Projected CAGR
20%
The compound annual growth rate for Operating Income over the next 8 years is 20%.
What is the Net Income forecast for CorMedix Inc?
Projected CAGR
13%
The compound annual growth rate for Net Income over the next 8 years is 13%.
